Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
목요일, 8월 27

Arcturus Therapeutics Holdings Inc

ARCTNASDAQ
Trade with Public
Trade with Public
$15.83
0.392.53%
가까이에: Aug 26, 5:00 PM EST
$15.95
0.120.76%
시간외: 6:54 PM EST
PRO
변동 이유?:Arcturus Therapeutics shares are trading higher. The company announced it w...
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

Arcturus Therapeutics Financials

Arcturus Therapeutics (ARCT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Arcturus Therapeutics Q2 EPS $(0.84) Beats $(1.00) Estimate, Sales $2.959M Miss $3.199M Estimate

Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(0.84) per share which beat the analyst consensus estimate of $(1.00) by 16 percent. This is a 147.06 percent decrease over losses of $(0.34) per share
Benzinga Newsdesk

PRO
Arcturus Therapeutics Q1 EPS $(0.95) Beats $(1.00) Estimate, Sales $2.061M Miss $7.233M Estimate

Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(0.95) per share which beat the analyst consensus estimate of $(1.00) by 5 percent. This is a 82.69 percent decrease over losses of $(0.52) per share from
Benzinga Newsdesk

Arcturus Therapeutics Q4 Earnings Assessment

Benzinga Insights

PRO
Arcturus Therapeutics Q4 EPS $(1.03) Misses $(0.98) Estimate, Sales $7.196M Miss $17.669M Estimate

Benzinga Newsdesk

Earnings Scheduled For March 3, 2026

Benzinga Insights

Earnings Preview: Arcturus Therapeutics

Benzinga Insights

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved